Hospira is a pharmaceutical and medical device company.
The company was formed in 2004 when Abbot Laboratories spun-off its hospital products division. The name “Hospira” was chosen by a vote of the employees and is a combination of the words hospital, spirit, inspire, and the Latin word for hope, spero.
At the time of the spin-off, Hospira had 14 manufacturing sites, 14,000 employees, and $2.5 billion in sales annually.
Today Hospira produces mostly generic specialty injectable pharmaceuticals for cardiovascular, anesthesia, oncology, and anti-infective therapies as well as pre-filled syringes. The company also manufactures electronic drug pumps and infusion therapy devices. Customers include wholesalers, drug manufacturers, nursing centers, outpatient surgical care facilities, and hospitals.
Hospira trades publicly on the New York Stock exchange under the ticker symbol HSP, is a member of the S&P 500, is #606 in the Fortune 500, has 17,000 employees, and had $4.42 billion in revenue in 2013.
HospiraHospira is a pharmaceutical and medical device company.
The company was formed in 2004 when Abbot Laboratories spun-off its hospital products division. The name “Hospira” was chosen by a vote of the employees and is a combination of the words hospital, spirit, inspire, and the Latin word for hope, spero.
At the time of the spin-off, Hospira had 14 manufacturing sites, 14,000 employees, and $2.5 billion in sales annually.
History
Today Hospira produces mostly generic specialty injectable pharmaceuticals for cardiovascular, anesthesia, oncology, and anti-infective therapies as well as pre-filled syringes. The company also manufactures electronic drug pumps and infusion therapy devices. Customers include wholesalers, drug manufacturers, nursing centers, outpatient surgical care facilities, and hospitals.
Hospira trades publicly on the New York Stock exchange under the ticker symbol HSP, is a member of the S&P 500, is #606 in the Fortune 500, has 17,000 employees, and had $4.42 billion in revenue in 2013.
